Hydrogen gas inhalation protects against cutaneous ischaemia/reperfusion injury in a mouse model of pressure ulcer.
マウス褥瘡モデルにおける皮膚虚血再灌流傷害に対する水素ガス吸入の保護効果
Abstract
Using a mouse model of repetitive cutaneous ischaemia/reperfusion (I/R) injury that mimics pressure ulcer formation, this study examined the effects of molecular hydrogen (H2) gas inhalation. H2 inhalation significantly reduced wound area, oxidative DNA damage (8-oxo-dG levels), and apoptosis rates in skin lesions. ROS accumulation was suppressed while antioxidant enzyme activities were enhanced through upregulation of Nrf2 and its downstream components in wound tissue and H2O2-treated endothelial cells. Endothelial overexpression of MCP-1, E-selectin, P-selectin, and ICAM-1 was attenuated, and infiltration of inflammatory cells along with production of TNF-α, IL-1, IL-6, and IL-8 was reduced. Concurrently, pro-healing mediators including IL-22, TGF-β, VEGF, and IGF1 were upregulated, MMP9 production was suppressed, and cutaneous collagen synthesis was accelerated. These findings indicate that H2 inhalation suppresses pressure ulcer development through coordinated antioxidant, anti-inflammatory, and wound-healing mechanisms.
Mechanism
H2 activates the Nrf2 pathway to enhance antioxidant enzyme activity and reduce ROS, suppresses endothelial adhesion molecules (MCP-1, E-selectin, P-selectin, ICAM-1) and pro-inflammatory cytokines (TNF-α, IL-1, IL-6, IL-8), upregulates pro-healing factors (IL-22, TGF-β, VEGF, IGF1), and inhibits MMP9 to promote collagen synthesis.
Bibliographic
- Authors
- Fang W, Wang G, Tang L, Su H, Chen H, Liao W, et al.
- Journal
- J Cell Mol Med
- Year
- 2018
- PMID
- 29921037
- DOI
- 10.1111/jcmm.13704
- PMC
- PMC6111801
Tags
Delivery context
In air, molecular hydrogen is reported to be combustible across approximately **4% (LFL, lower flammability limit) to 75% (UFL, upper flammability limit)**. Among high-concentration hydrogen inhalers, 66% output sits inside this range, and even pure-hydrogen (100%) output forms a 4–75% concentration-gradient layer at the device–air boundary (the UFL 75% paradox). Engineering principle would therefore call for operation below LFL (the classical 4%); that figure, however, was measured under closed, pre-mixed, static conditions. For the open, dynamic inhalation environment, the empirical value reported in the literature is **10%**, which is the figure referenced in practice as the operating ceiling. The 66% / 100% output devices are recorded in the Japanese Consumer Affairs Agency accident-information database, and from these considerations are not recommended.
Safety notes
See also: